High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer shared his thoughts on as he discussed Big Tech’s AI spending. Cramer discussed the company’s “great” quarter during the episode, as he said: In Friday night’s game plan, I told you to expect a great quarter from CVS Health, and that’s exactly what we […]
We recently published Jim Cramer Said Sandisk Stock Performance is Befuddling & Discussed These 17 Stocks. CVS Health Corporation (NYSE:CVS) is one of the stocks discussed by Jim Cramer. CVS Health Corporation (NYSE:CVS) continues to be favored by Jim Cramer in the pharmaceutical retailer space. Its shares are up by 30% over the past year […]
To understand whether CVS Health stock might still offer value at around US$87.36, you need to know how that price compares with what the business could be worth using different valuation checks. Recent share price moves have been meaningful, with the stock showing returns of 4.9% over 7 days, 11.7% over 30 days, 9.0% year to date, 33.5% over 1 year, 42.3% over 3 years and 22.4% over 5 years, which can change how investors view both opportunity and risk. Alongside these returns, CVS Health...
CVS Health (NYSE:CVS) is rolling out major biosimilar formulary updates that are expected to affect prescription choices and costs across its pharmacy network. The company is expanding acceptance of WIC benefits statewide in Rhode Island for infant formula, broadening access for eligible families. CVS Health is adding new community partnerships and AI-driven initiatives focused on affordability, nutrition, and local health support. For investors tracking NYSE:CVS, these moves sit alongside...
The most significant insight currently obscured by CVS Health's (CVS) headline revenue growth is a high-stakes transition: the company is attempting to use a temporary surge in insurance profitability to outrun the structural margin pressures facing its pharmacy benefit management (PBM) business.
Knorr-Bremse (ETR:KBX) opened 2026 with what CEO Marc Llistosella described as the company’s “best first quarter in the past 5 years,” citing margin recovery in the commercial vehicle business and a record order backlog in its rail division. Management also reiterated its full-year guidance, while n
CVS lifted adjusted earnings guidance after first-quarter profit and revenue beat expectations, helped by reserve benefits and stronger Aetna profitability.
Oil prices fell and stocks rose on rising optimism about an end to Middle East hostilities. Iran and the U.S. are working with mediators on a one-page framework to restart negotiations aimed at ending the conflict and opening the Strait of Hormuz, with talks potentially beginning next week in Islamabad. Semiconductor stocks extended their rally.
The ubiquitous pharmacy retailer crushed first-quarter analyst estimates.
Health care stocks were higher late Wednesday afternoon, with the NYSE Health Care Index increasing
Health care stocks were mixed Wednesday afternoon, with the NYSE Health Care Index increasing 0.1% a
CVS Health Corp (NYSE:CVS) shares rose about 6% on Wednesday morning after the retail pharmacy chain reported first quarter financial results that topped Wall Street expectations on both earnings and revenue. The company posted adjusted earnings per share (EPS) of $2.57, compared with analyst...
Private Payrolls Increased More Than Expected
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.